![David Patience](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Patience
Financieel Directeur/CFO bij
TRISALUS LIFE SCIENCES, INC.
Vermogen: 1 M $ op 30-06-2026
Profiel
David Patience is Chief Financial Officer at TriSalus Life Sciences, Inc. since 2025.
Previously, Chief Financial Officer at Accelerate Diagnostics, Inc. from 2023 to 2025.
Education includes an MBA from The University of Chicago Booth School of Business and an undergraduate degree from The Leeds School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-07-2026 | 261.107 ( 0,43% ) | 1 M $ | 30-06-2026 |
Actieve functies van David Patience
| Bedrijven | Functie | Begin |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Financieel Directeur/CFO | 01-07-2025 |
Eerdere bekende functies van David Patience
| Bedrijven | Functie | Einde |
|---|---|---|
| ACCELERATE DIAGNOSTICS, INC. | Financieel Directeur/CFO | 30-06-2025 |
Opleiding van David Patience
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
12
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Accelerate Diagnostics, Inc.
 Accelerate Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostics solutions | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leeds School of Business
 The Leeds School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TriSalus Life Sciences, Inc.
 TriSalus Life Sciences, Inc. Medical SpecialtiesHealth Technology Engages in research, development and sales of innovative drug delivery technology & immune-oncology therapeutics | Health Technology |
Kies MarketScreener 
